Trial Profile
A Phase I, Open-Label, Single-Sequence Drug-Drug Interaction Trial to Investigate the Pharmacokinetic Interaction Between Steady-State Nevirapine and Single-Dose TMC207 in HIV-1 Infected Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Bedaquiline (Primary) ; Nevirapine
- Indications HIV-1 infections; Tuberculosis
- Focus Pharmacokinetics
- Sponsors Janssen Infectious Diseases BVBA
- 08 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 08 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 08 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.